Smoking-related dysregulation of plasma circulating microRNAs: the Rotterdam study.

"Declarations Ethics approval and consent to participateThe study has been conducted within the Rotterdam study, which was approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272-159521-PG). The Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; www.trialregister.nl) and into the WHO International Clinical Trials Registry Platform (ICTRP; www.who.int/ictrp/network/primary/en/) under shared catalogue number NTR6831. Consent for publicationNot applicable. Competing interestsThe authors declare no conflict of interest. Competing interests The authors declare no conflict of interest."

"Funding The Rotterdam Study is supported by the Erasmus Medical Center and the Erasmus University Rotterdam, the Netherlands Organization for Scientific Research (NWO), the Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture, and Science, the Ministry of Health, Welfare and Sports, the European Commission (DG XII), and the municipality of Rotterdam. MiRNA expression profiling was funded by the Janssen Prevention Center of Janssen Vaccines and Prevention BV, part of the Janssen Pharmaceutical Companies of Johnson & Johnson. The project was partly supported by the Erasmus MC Fellowship grant (EMCF20213) of Mohsen Ghanbari. The mentioned funders had no role in the design and conduct of the study, nor in the decision to submit the manuscript for publication."

"Declarations: Ethics approval and consent to participateThe study has been conducted within the Rotterdam study, which was approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272-159521-PG). The Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; www.trialregister.nl) and into the WHO International Clinical Trials Registry Platform (ICTRP; www.who.int/ictrp/network/primary/en/) under shared catalogue number NTR6831.: Consent for publicationNot applicable.: Competing interestsThe authors declare no conflict of interest. Ethics approval and consent to participate: The study has been conducted within the Rotterdam study, which was approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272-159521-PG). The Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; www.trialregister.nl) and into the WHO International Clinical Trials Registry Platform (ICTRP; www.who.int/ictrp/network/primary/en/) under shared catalogue number NTR6831."